Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Sny crawled date : 2021 - 07 - 29 save search
bluebird bio and National Resilience Ink Cell Therapy Strategic Alliance
Published: 2021-07-29 (Crawled : 18:00) - biospace.com/
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.69%
H: 0.08%
C: -0.33%
therapy
L'Oréal: News release: "2021 Half-Year Results"
Published: 2021-07-29 (Crawled : 17:00) - globenewswire.com
ARVL | News | $0.49 0.37% 2.5M
|
Manufacturing
|
| O: 0.96%
H: 1.25%
C: -4.41%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.69%
H: 0.08%
C: -0.33%
results
Online availability of Sanofi’s half-year financial report for 2021
Published: 2021-07-29 (Crawled : 17:00) - globenewswire.com
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.69%
H: 0.08%
C: -0.33%
financial report
Future of AstraZeneca’s Vaccine Business is Murky, But Seeks to Move Ahead wi...
Published: 2021-07-29 (Crawled : 16:00) - biospace.com/
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.69%
H: 0.08%
C: -0.33%
vaccine
Biologics Market Size to Reach USD 477.15 Billion in 2027 | Rapid Advancements in Molecular Therapy and Cell-Based Biologics, Increasing Incidence of Chronic Diseases, are Some Key Factors Driving Industry Growth, says Emergen Research
Published: 2021-07-29 (Crawled : 15:15) - prnewswire.com
NVO | News | $126.16 -1.93% -0.23% 3.1M
|
Health Technology
|
| O: 0.49%
H: 0.26%
C: -0.62%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: 0.33%
H: 0.35%
C: -0.32%
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: 0.4%
H: 0.08%
C: -0.13%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.69%
H: 0.08%
C: -0.33%
disease therapy molecular growth research merge
Future of AstraZeneca’s Vaccine Business is Murky, But Seeks to Move Ahead with FDA Filing
Published: 2021-07-29 (Crawled : 15:15) - biospace.com/
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.69%
H: 0.08%
C: -0.33%
fda vaccine
New Day For Diabetes Patients As FDA Approves First-Ever Interchangeable Biosimilar
Published: 2021-07-29 (Crawled : 14:00) - biospace.com/
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.69%
H: 0.08%
C: -0.33%
diabetes fda fda approval biosimilar
New Day For Diabetes Patients As FDA Approves First-Ever Interchangeable Bios...
Published: 2021-07-29 (Crawled : 14:00) - biospace.com/
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.69%
H: 0.08%
C: -0.33%
diabetes fda fda approval
Merck Announces Second-Quarter 2021 Financial Results
Published: 2021-07-29 (Crawled : 12:00) - biospace.com/
MRK | $127.0 0.1% -1.21% 7.1M
|
Health Technology
|
| O: -1.0%
H: 0.48%
C: -0.8%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.69%
H: 0.08%
C: -0.33%
financial results results
Quell Therapeutics Appoints Tracey Lodie, Ph.D., as Chief Scientific Officer
Published: 2021-07-29 (Crawled : 09:00) - prnewswire.com
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.69%
H: 0.08%
C: -0.33%
therapeutics
Dupixent® (dupilumab) Significantly Improved Itch and Hives in Patients with Chronic Spontaneous Urticaria, a Step Forward in Demonstrating the Role of Type 2 Inflammation in These Patients
Published: 2021-07-29 (Crawled : 06:00) - prnewswire.com
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.69%
H: 0.08%
C: -0.33%
REGN | News | $906.55 -0.09% -0.08% 370K
|
Health Technology
|
| O: 0.38%
H: 0.52%
C: -0.93%
hiv urticaria dupixent
Sales growth accelerated - Full-year guidance raised
Published: 2021-07-29 (Crawled : 06:00) - globenewswire.com
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.69%
H: 0.08%
C: -0.33%
sales growth
Sanofi appoints new leaders to Executive Committee and announces future Chair of EUROAPI
Published: 2021-07-29 (Crawled : 06:00) - globenewswire.com
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.69%
H: 0.08%
C: -0.33%
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.